13D Filing: QVT Financial and Arbutus Biopharma Corp (ABUS)

Page 8 of 9 – SEC Filing


The Preferred Shares will rank senior to the Common Shares with respect to any distributions or
rights upon liquidation, dissolution or winding up of the Issuer.

Voting Rights

The Preferred Shares will not have the right to vote on any matters except as required by law, including under the British Columbia Business
Corporations Act.

The foregoing description of the Preferred Share Articles Amendment does not purport to be complete and is qualified in
its entirety by reference to the form of the Preferred Share Articles Amendment, which is filed as an exhibit to this Schedule 13D and is incorporated herein by reference.

Item 7. Material to Be Filed as Exhibits

Item 7 of the Original Schedule 13D is hereby amended
by adding thereto the following information:

Exhibit 1. Form of Terms Of Series A Participating Convertible Preferred Stock Of Arbutus Biopharma Corporation, incorporated by reference to Schedule B to Exhibit 7.08 to the Schedule 13D/A of Roivant Sciences Ltd. filed with the Securities
and Exchange Commission on October 3, 2017.

8

Follow Arbutus Biopharma Corp (NASDAQ:ABUS)